Taken together, these data caution against GABPA being a universal regulator of the mutant TERT promoter in thyroid cancer cells and suggest that targeting GABPA over a sustained period is unlikely to result in a consistent reduction in TERT expression in this tumor type. Here, TERT is linked to neoplasm.